San FranciscoFounded 20242+ employeesPrivate
$500K raisedSeed· last: pre seed (Sep 2024)· 1 rounds
Backed by(2 investors)
Y Combinator · Lead+1 more
Kopra Bio makes genetically engineered viruses that teach your immune system to kill cancer using tech we developed at UCSF. We’re making the next Keytruda ($25B/yr cancer drug blockbuster) starting with the most aggressive form of brain cancer, glioblastoma. In the most challenging brain cancer model, we improve survival from 0% with the current FDA approved treatment to 90% with our treatment.
